Sana Biotechnology, Inc. (SANA)

NASDAQ: SANA · IEX Real-Time Price · USD

9.78

+0.15 (1.56%)

At close: May 2, 2024, 4:00 PM

8.50

-1.28 (-13.09%)

Pre-market: May 3, 2024, 4:55 AM EDT

Sana Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,165	804	753	2,923	-	-
Market Cap Growth	-	6.76%	-74.23%	-	-	-
Enterprise Value	2,060	699	432	2,483	-308	-93
PE Ratio	-2.84	-2.84	-2.80	-8.21	-	-
PB Ratio	7.53	2.80	1.51	4.01	-	-
P/FCF Ratio	-2.94	-2.94	-2.42	-10.41	-	-
P/OCF Ratio	-3.17	-3.17	-2.60	-11.64	-	-
EV/EBITDA Ratio	-2.85	-2.85	-1.79	-7.35	1.12	0.69
EV/EBIT Ratio	-2.47	-2.47	-1.60	-6.98	1.08	0.67
EV/FCF Ratio	-2.56	-2.56	-1.39	-8.84	1.91	0.83
Debt / Equity Ratio	0.36	0.36	0.22	0.15	-0.17	-0.33
Debt / EBITDA Ratio	-0.42	-0.42	-0.45	-0.33	-0.26	-0.35
Debt / FCF Ratio	-0.38	-0.38	-0.35	-0.39	-0.44	-0.43
Quick Ratio	3.24	3.24	3.86	5.55	12.10	7.28
Current Ratio	3.31	3.31	3.99	5.62	12.22	7.47
Return on Equity (ROE)	-78.90%	-78.90%	-44.80%	-42.50%	101.20%	168.00%
Return on Assets (ROA)	-42.70%	-42.70%	-28.80%	-28.90%	-49.80%	-58.20%
Return on Capital (ROIC)	-74.86%	-74.86%	-44.86%	-42.52%	81.93%	148.83%
Earnings Yield	-13.09%	-35.22%	-35.77%	-12.18%	-	-
FCF Yield	-12.64%	-34.02%	-41.27%	-9.61%	-	-
Buyback Yield / Dilution	-3.29%	-3.29%	-13.17%	-1178.88%	-165.43%	-414.97%
Total Shareholder Return	-3.29%	-3.29%	-13.17%	-1178.88%	-165.43%	-414.97%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).